Our passion for making a difference unites us.
Amicus Therapeutics is a global, patient-dedicated biotech focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic
diseases.
KatelynnAge 11
Living with CDKL5 Deficiency Disorder
About Amicus
We are a biotechnology company at the forefront of advanced therapies to treat a range of devasting rare diseases.
Extraordinary Patient Focus
At Amicus, patient-centricity is in our DNA. See how our commitment to patients goes further than just our medicines and expands out to the rare disease community at large.
News & Announcements
February 19, 2020
Amicus Therapeutics to Announce Full-Year 2019 Financial Results on March 2, 2020
February 7, 2020
Amicus Therapeutics Announces Presentations and Posters at 16th Annual WORLDSymposium™ 2020
January 13, 2020
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
January 9, 2020
Amicus Therapeutics Announces Preliminary 2019 Galafold Revenue - Exceeding Upper End of Prior Guidance
Programs & Pipeline
We are leveraging our innovative technology platforms to develop treatments for human genetic diseases.
Career @ Amicus
Join a team committed to changing the lives of patients with rare metabolic diseases. Now hiring in multiple locations.